Suzanne Fleming

Suzanne Fleming

No más puestos en curso
65 años
Health Technology
Commercial Services
Finance

Perfil

Suzanne Fleming is currently the Chief Accounting Officer at Beam Therapeutics, Inc. She previously held positions as the Senior Director-Finance at TransForm Pharmaceuticals, Inc. from 2003 to 2005, Principal at Transkaryotic Therapies, Inc., Principal at Oculon Corp from 1991 to 1995, Principal at CytoTherapuetics, Inc. from 1995 to 1998, Vice President-Finance at AVEO Pharmaceuticals, Inc. from 2005 to 2013, Treasurer, Chief Financial & Accounting Officer at Epizyme, Inc. from 2017 to 2019, and Vice President-Finance at Foundation Medicine, Inc. from 2014 to 2017.
She obtained her undergraduate degree from Stonehill College, Inc.

Antiguos cargos conocidos de Suzanne Fleming.

EmpresasCargoFin
EPIZYME, INC. Director Financiero/CFO 31/01/2019
FOUNDATION MEDICINE INC Corporate Officer/Principal 01/09/2017
AVEO PHARMACEUTICALS, INC. Director Financiero/CFO 05/04/2011
Director Financiero/CFO 01/01/2005
Corporate Officer/Principal 01/01/1998
Ver el detalle de la experiencia de Suzanne Fleming.

Formación de Suzanne Fleming.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

66

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Commercial Services

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

40% de descuento. Las herramientas más útiles solo para suscriptores: ¡descubre las mejores inversiones del futuro!
d
:
:
APROVECHAR LA PROMOCIÓN